Technical Analysis for CYAD - Celyad SA

Grade Last Price % Change Price Change
F 6.55 1.71% 0.11
CYAD closed up 1.71 percent on Wednesday, April 21, 2021, on 2.21 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CYAD trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 1.71%
New 52 Week Closing Low Bearish 1.71%
Expansion Breakdown Bearish Swing Setup 1.71%
Wide Range Bar Range Expansion 1.71%
New 52 Week Low Weakness 1.71%
BB Squeeze Ended Range Expansion 1.71%
Older End-of-Day Signals for CYAD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % 2 days ago
Down 1% 2 days ago
Fell Below Previous Day's Low 2 days ago
10 DMA Resistance 3 days ago
Up 2% 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure, allows the differentiation of a patient's own cells into cardiopoeitic cells which grow into new heart cells and repair heart muscle. C-Cure consists of autologous adult stem cells guided in vitro to the cardiac lineage before implantation in the failing heart. Furthermore, the Company is involved in the field of immuno-oncology, through its subsidiary, OnCyte.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cells Injury Cardiovascular Disease In Vitro Adult Stem Cell Stem Cell Therapy Induced Stem Cells Therapies For Cardiovascular Disease

Is CYAD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.01
52 Week Low 6.06
Average Volume 16,685
200-Day Moving Average 8.69
50-Day Moving Average 7.39
20-Day Moving Average 6.97
10-Day Moving Average 6.83
Average True Range 0.34
ADX 44.82
+DI 5.45
-DI 31.94
Chandelier Exit (Long, 3 ATRs ) 6.72
Chandelier Exit (Short, 3 ATRs ) 7.08
Upper Bollinger Band 7.38
Lower Bollinger Band 6.55
Percent B (%b) 0.0
BandWidth 12.02
MACD Line -0.21
MACD Signal Line -0.19
MACD Histogram -0.0244
Fundamentals Value
Market Cap 91.32 Million
Num Shares 13.9 Million
EPS -7.01
Price-to-Earnings (P/E) Ratio -0.93
Price-to-Sales 9643.83
Price-to-Book 3.61
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.06
Resistance 3 (R3) 7.05 6.87 6.97
Resistance 2 (R2) 6.87 6.74 6.87 6.95
Resistance 1 (R1) 6.71 6.66 6.62 6.72 6.92
Pivot Point 6.53 6.53 6.49 6.54 6.53
Support 1 (S1) 6.37 6.40 6.28 6.38 6.18
Support 2 (S2) 6.19 6.32 6.20 6.15
Support 3 (S3) 6.03 6.19 6.13
Support 4 (S4) 6.04